Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06208943 · ClinicalTrials.gov registry record
Neural and Cognitive Consequences of COVID-19 Survival
A clinical trial of COVID-19 and Fatigue, sponsored by San Francisco Veterans Affairs Medical Center.
- Recruiting
- Registry status
- 150
- Enrollment target
- 1
- Study location
NCT06208943 is a study of COVID-19 and Fatigue that is actively recruiting participants, run by San Francisco Veterans Affairs Medical Center. The registered enrollment target is 150 participants, below the 55,214-participant average among 203 other COVID-19 trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state.
The verdict
NCT06208943, a study of COVID-19 and Fatigue, is actively recruiting participants, sponsored by San Francisco Veterans Affairs Medical Center.
- RECRUITING
- Registry status
- 150 participants
- Enrollment target
- 1
- Study location
Study Summary
The novel coronavirus SARS-CoV-2 infection, COVID, continues to rage throughout the world with 115,000,000 confirmed cases and over 2,500,000 deaths (as of Mar 3, 2021). This translates to millions of people surviving COVID19 infection. While the lungs are ground zero, COVID tears through organ systems from brain to blood vessels. We are now beginning to see people recover but complain of ongoing problems, including lingering cognitive problems, depression, and anxiety. We have brought together 2 laboratories with complementary techniques including psychological testing and neuroimaging methods togethers with markers in the blood that may signal damage in the brain. A close look at these problems is timely and imperative if we are to understand the pathophysiology of 'COVID brain' and prepare for downstream problems.
Conditions Studied
Interventions
- OTHER cross-sectional MRI and EEG assessments (NO INTERVENTION)
Study Locations (1)
California
- San Francisco Heathcare System - San Francisco
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 150 participants |
| Start Date | 2021-10-01 |
| Est. Completion | 2025-09-30 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06208943
The ClinicalTrials.gov registry entry for NCT06208943 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 150 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 55,214-participant average among 203 other COVID-19 trials with a reported enrollment target (100% lower). The listed sponsor is San Francisco Veterans Affairs Medical Center, which has 15 total studies on file at ClinicalTrials.gov.
The record links to 7 conditions, with COVID-19 appearing as the primary indexed condition, and to 1 intervention - of which cross-sectional MRI and EEG assessments (NO INTERVENTION) is the first listed.
NCT06208943 reports 1 study location spanning 1 distinct geographic area - top geographies include California.
Frequently Asked Questions
What is clinical trial NCT06208943 about?
NCT06208943 is a clinical study titled "Neural and Cognitive Consequences of COVID-19 Survival". The novel coronavirus SARS-CoV-2 infection, COVID, continues to rage throughout the world with 115,000,000 confirmed cases and over 2,500,000 deaths (as of Mar 3, 2021). This translates to millions of people surviving COVID19 infection. While the lungs are ground zero, COVID tears through organ syst...
What is the current status of trial NCT06208943?
This trial is currently recruiting. The enrollment target is 150 participants. The study started on 2021-10-01. Estimated completion is 2025-09-30.
What conditions does trial NCT06208943 study?
This clinical trial studies the following conditions: COVID-19, Fatigue, Brain Fog, COVID Long-Haul, COVID-19 Pandemic.
What interventions are being tested in trial NCT06208943?
The interventions under investigation include: cross-sectional MRI and EEG assessments (NO INTERVENTION) (OTHER).
Who is sponsoring clinical trial NCT06208943?
This trial is sponsored by San Francisco Veterans Affairs Medical Center, which has 15 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06208943 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for COVID-19
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
CArdiac REhabilitation for Building Exertional heArt Rate for Chronotropic Incompetence in Long COVID-19
RECRUITING · NA
-
Arginine Replacement Therapy in COVID-19
RECRUITING · Phase 2
-
A Study to Learn About Variant-Adapted COVID-19 RNA Vaccine Candidate(s) in Healthy Children
RECRUITING · Phase 2
-
Cardiac Magnetic Resonance Tissue Characterization in COVID-19 Survivors
RECRUITING
-
COVID-19 Health Adjustments in Nutrition, General Wellness, and Exercise
RECRUITING
-
The Impact of COVID-19 on Maternal and Neonatal Outcomes
RECRUITING
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.